scispace - formally typeset
Z

Zhaofei Liu

Researcher at Peking University

Publications -  77
Citations -  3790

Zhaofei Liu is an academic researcher from Peking University. The author has contributed to research in topics: In vivo & Cancer. The author has an hindex of 32, co-authored 67 publications receiving 3175 citations. Previous affiliations of Zhaofei Liu include Peking Union Medical College Hospital & RMIT University.

Papers
More filters
Journal ArticleDOI

Integrin αvβ3-targeted cancer therapy

TL;DR: The role of integrin αvβ3 in angiogenesis is reviewed, recent progress in the use ofIntegrin α vβ3 antagonists and integrin‐targeted delivery systems as potential cancer therapeutics are presented, and future perspectives are discussed.
Journal ArticleDOI

NaGdF4 Nanoparticle-Based Molecular Probes for Magnetic Resonance Imaging of Intraperitoneal Tumor Xenografts in Vivo

TL;DR: Investigation demonstrated that the water-soluble NaGdF(4) nanocrystals, coated by PEG bearing two phosphate groups on the same side, exhibit not only excellent colloidal stability in water and PBS buffer, but also higher T1 relaxivity than Gd-DTPA (Magnevist).
Journal ArticleDOI

Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes

TL;DR: Results demonstrate that tumor-targeted PDT using GO(HPPH)-PEG-HK could effectively ablate primary tumors and destroy residual tumor cells, thereby preventing distant metastasis by activating host antitumor immunity and suppressing tumor relapse by stimulation of immunological memory.
Journal ArticleDOI

Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice

TL;DR: It is shown that molybdenum-based polyoxometalate nanoclusters with preferential renal uptake and can ameliorate AKI pathology in mice by scavenging reactive oxygen species.
Journal ArticleDOI

Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.

TL;DR: Biodistribution studies clearly demonstrated that PEG( 4) linkers are particularly useful for improving the tumor uptake and clearance kinetics of (99m)Tc-2PEG(4)-dimer and ( 99m) tricine-3PEG (4-dimer) from noncancerous organs.